ABIOSCIENCES INC

ABIOSCIENCES INC specializes in analytical laboratory testing services, delivering precision scientific support for public health and biomedical research initiatives. Their core capabilities center on clinical and environmental sample analysis, including molecular diagnostics, biomarker validation, and quality-controlled testing protocols aligned with federal regulatory standards. The company applies rigorous methodological frameworks to ensure data integrity, chain-of-custody compliance, and reproducibility in high-stakes testing environments. While their award history reflects a focused scope, their work demonstrates proficiency in executing complex laboratory workflows under stringent oversight, with an emphasis on accuracy, timeliness, and adherence to Good Laboratory Practices (GLP). Their technical expertise likely encompasses chromatography, spectrometry, PCR-based assays, and data management systems compliant with 21 CFR Part 11. The contractor has delivered testing services to the Department of Health and Human Services, indicating direct engagement in federal health surveillance, infectious disease monitoring, or public health emergency response efforts. Their relationship with HHS suggests alignment with CDC, NIH, or ASPR initiatives requiring certified laboratory output for population-level health assessments. ABIOSCIENCES INC operates within NAICS 541380, which encompasses independent testing laboratories providing analytical services to government and private sector clients. In practice, this means they function as a contracted scientific resource for regulatory compliance, research validation, or public health data generation—positioning them as a specialized vendor in the federal life sciences ecosystem. As a small business structured as a 2L entity based in South San Francisco, ABIOSCIENCES INC benefits from proximity to biotech and academic research hubs. While they hold no formal government certifications, their operational model reflects the discipline required for federal laboratory contracting, emphasizing procedural rigor and regulatory alignment over formal accreditations. Their geographic footprint is currently centered in California’s biotech corridor, supporting targeted engagement with federal health agencies.